(Q34531927)

English

Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Kenneth N Sall

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Linda J Greff

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Lisa R Johnson-Pratt

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Paul T DeLucca

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Adam B Polis

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Andrea H Kolodny

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Charlena A Fletcher

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Deborah A Cassel

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Denise R Boyle

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Franck Skobieranda

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

110

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

615-624

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901900-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901900-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Dorzolamide-Timolol Combination Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901900-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901900-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901900-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative acute effects of brimonidine 0.2% versus dorzolamide 2% combined with beta-blockers in glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901900-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901900-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Visual ability and drug regimen: relation to compliance with glaucoma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901900-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Accuracy of doctors' estimates and patients' statements on adherence to a drug regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901900-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(02)01900-0

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34531927&oldid=1619579358"